Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's Drug Shortages Strategy Focuses On Prevention, Not "Empire Building"

Executive Summary

FDA would like additional funding for a number of its programs, but it does not appear that the agency will be pushing to expand its drug shortage team.
Advertisement

Related Content

“Comprehensive” Drug Shortage Mitigation Bill Under Development In House
Medicare Reimbursement Rate Targeted As Culprit For Drug Shortages
Obama's Drug Shortage Efforts Focus On Personnel, Persuasion
38 Special: How FDA Shot Down Drug Shortages In 2010
Drug Shortages: Can The Blame Game Help Find Solutions?
38 Special: How FDA Shot Down Drug Shortages In 2010
Drug Shortages: Can The Blame Game Help Find Solutions?
Drug Shortages: FDA Wants Advanced Warning; Practitioners Want Even More
To Prevent Drug Shortages, Don't Look To Inspections, FDA Says
Drug Shortage Legislation Gains Momentum With Bipartisan House Bill

Topics

Advertisement
UsernamePublicRestriction

Register

PS053816

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel